Protect your health with a COVID-19 vaccine

Watch a video to learn COVID-19 vaccine safety and why they're recommended. 

The FDA has approved the COVID-19 vaccine for use in preventing serious illness from COVID-19 among people ages 16 and older. COVID-19 vaccines are also emergency-use authorized (EUA), among people age 12 and older to help prevent serious illness from COVID-19, by the FDA. For people who have certain immunocompromised conditions, the FDA authorized an extra dose of the two-dose COVID-19 vaccines to help maximize protection for this population. Details can be found in the chart below.

Like the flu vaccine, vaccination providers will administer the COVID-19 vaccine based on availability. Vaccination providers may not have all FDA-authorized and FDA-approved COVID-19 vaccines at their location.

Important reminders on the protection COVID-19 vaccines provide: 

• Like other vaccines, COVID-19 vaccines can take several weeks after vaccination completion for full effectiveness. 
• Fully vaccinated people may carry the virus after exposure, even if they are not showing symptoms. Masks used in indoor and public places help prevent exposure. 
• The duration of protection against COVID-19 is currently unknown and being studied.

Because of this, keep following public health safety guidelines to help protect yourself and others. For the latest information, go to the CDC.

All FDA-authorized and FDA-approved COVID-19 vaccines are safe and effective at preventing serious illness from COVID-19, according to the CDC. If you have questions about which vaccine might be right for you, talk to your primary care provider or other health care professional. 

Learn more about the Janssen COVID-19 vaccine on the CDC website.  

The safety of vaccines is a top priority, and millions of people have already been safely vaccinated. All FDA-authorized and FDA-approved COVID-19 vaccines are safe and effective at preventing serious illness, including hospitalization and death, from COVID-19, according to the CDC. They are key to slowing the pandemic. The U.S. vaccine safety system makes sure all vaccines go through an extensive process to confirm levels of safety. The recently FDA-authorized COVID-19 vaccines went through this process. Even after emergency use authorization, the FDA continues to review clinical data about the vaccines.

Approval is granted once the FDA determines the vaccine to be safe and effective at preventing serious illness from COVID-19. The FDA goes through a detailed review of clinical data and information, as submitted in the Biologics License Application (BLA).

The CDC website has additional COVID-19 vaccine safety information.

Side effects from vaccines are normal signs that your body is building protection. As with other vaccines and according to the CDC, people have reported some side effects with FDA-authorized and FDA-approved COVID-19 vaccines. The most common side effect is a sore arm. Some other side effects may feel like flu and might even affect your ability to do daily activities. But they should go away in a few days. You can learn more on the CDC website.

In the event of an emergency, you should call 911 or go to the nearest hospital.

If you have side effects that bother you or do not go away, you should report them to your vaccination provider or primary care provider. You should also notify the CDC at 1-800-822-7967. This is because the CDC and FDA continue to monitor the safety of the FDA-authorized and FDA-approved COVID-19 vaccines. You can also use the CDC’s v-safe mobile app, which will help you monitor side effects and get second dose reminders.

The FDA approval determined that the vaccine is safe and effective at preventing COVID-19. The FDA goes through a detailed review of clinical data and information, as submitted in the Biologics License Application (BLA). In addition, the Advisory Committee on Immunization Practices (ACIP) and the CDC have recommended the FDA-approved vaccine for use among people age 16 and older.

The COVID-19 vaccine with FDA approval is the Pfizer-BioNTech COVID-19 Vaccine, which will be known as Comirnaty. This vaccine was approved for use in preventing COVID-19 among people age 16 and older, and continues to be authorized for emergency use to prevent COVID-19 among people 12 to 15 years old and those with certain immunocompromised conditions, as defined by the CDC.

The FDA-authorized and FDA-approved COVID-19 vaccines are not recommended for people with certain conditions or of different ages. The current vaccines are authorized for use among the following ages:

• Pfizer is not authorized for people under the age of 12.
• Moderna is not authorized for people under the age of 18.
• Johnson & Johnson's Janssen is not authorized for people under the age of 18 and it is not authorized for a second dose. 

Per the FDA, women younger than 50 years old should be aware of the rare risk of blood clots with low platelets after Janssen vaccination. Other COVID-19 vaccines, such as Pfizer and Moderna, are available where this risk has not been seen.

There are other special considerations for when it might not be a good time to get the vaccine:

• If you've recently been exposed to COVID-19, see the CDC guidelines for getting the vaccine. 
• If you’ve had monoclonal antibody treatment or received convalescent plasma, the CDC states vaccination should not occur for at least 90 days.

Talk to your health care provider if you have questions about getting vaccinated for COVID-19.

According to the CDC, if you have ever had a severe allergic reaction to a vaccine or an injected medicine, you should ask your doctor if you should get a COVID-19 vaccine. A severe reaction is one that requires treatment at a hospital or with medications like an EpiPen (epinephrine). According to the CDC, the likelihood of severe reaction to the FDA-authorized COVID-19 vaccines is very low.    

The CDC recommends the people who have seasonal allergies or allergies to food, pets or oral medications, can still be vaccinated. If you have any questions, you should check with your health care provider. 

For more information, you can read the FDA’s fact sheets: Pfizer, Moderna and Johnson & Johnson's Janssen.

Not at this time. Pfizer/BioNTech is evaluating a smaller dose vaccine of approximately 1/3rd the adult dose in children ages 5 to 11. We anticipate peer review of vaccine efficacy in this age group soon. 

Pfizer has indicated that they will be submitting the results to the FDA for review and apply for an emergency use authorization (EUA) around the end of September. If authorized by the FDA and subsequently recommended by the CDC it may be available later in 2021.  For reference, please read the full Pfizer press release.

According to the CDC, the FDA-approved Pfizer-BioNTech Comirnaty COVID-19 vaccine and the FDA-authorized Pfizer-BioNTech COVID-19 vaccine have the same formulation and may be used interchangeably. The Pfizer-BioNTech COVID-19 vaccine administered for the first two doses of COVID-19 vaccine is the same formulation as the additional third dose and booster dose.

The Moderna COVID-19 vaccine administered for the first two doses of COVID-19 vaccine is the same formulation as the additional third dose. At this time, Moderna COVID-19 vaccine does not have EUA for a booster dose.

COVID-19 vaccination is recommended by the CDC and the American College of Obstetricians and Gynecologists for all people age 12 years and older. This includes people who are pregnant, breastfeeding, trying to get pregnant now or might become pregnant in the future. Pregnant and recently pregnant people are more likely to get severely ill with COVID-19 compared with non-pregnant people. Getting a COVID-19 vaccine can protect you from severe illness from COVID-19.

If you have questions, a conversation with your health care provider about the COVID-19 vaccine may be helpful.  

There is no evidence that the vaccine has any effect on male or female fertility. When the vaccine is given during pregnancy, the vaccine allows the mother to create antibodies which then protect both the mother and baby from infection.

According to the CDC, COVID-19 vaccinations should be offered to people regardless of whether they have previously had COVID-19. You do not need an antibody or diagnostic test before or after you are vaccinated to learn if the vaccine worked.

Anyone currently infected with COVID-19 should wait to get vaccinated until after their illness has resolved and after they have met the criteria to discontinue isolation. Additionally, current evidence suggests that reinfection with the virus that causes COVID-19 is uncommon in the 90 days after initial infection. So, people with a recent infection may delay vaccination until the end of that 90-day period.

According to the CDC, experts are continuing to study the variants of the virus that causes COVID-19. Viruses constantly change through mutation, and new variants of a virus are expected to occur over time. There are multiple variants of the virus that causes COVID-19 in the United States, and these variants seem to spread more easily than other variants. An increase in cases of COVID-19 can lead to more hospitalizations and potentially more deaths.

FDA-authorized and FDA-approved COVID-19 vaccines help prevent the virus from spreading, which in turn can help decrease the opportunity for virus variants to develop and spread. According to the CDC, vaccines do help with protect against variants, and they continue to be closely investigated with more studies underway.

Vaccines play an essential role in limiting the spread of COVID-19 and protecting people’s health. To help protect your and your loved one’s health, you also need to follow public health safety practices:

• Wear face masks
• Physically distance
• Wash your hands regularly
• Isolate or quarantine when sick
  

 Visit the CDC website to learn more about the virus variants.

 The American Academy of Pediatricians and the American Medical Association support face masks as a science-based tool in helping prevent and control COVID-19.  Masks help keep your respiratory droplets in, while keeping other people’s droplets out. They are effective in helping slow the spread of COVID-19, especially for 1) both vaccinated and unvaccinated people in highly-impacted areas, and, and 2) people and households who are not yet vaccinated or have an underlying medical condition, according to the CDC.

Make sure your mask works the best it can, according to the CDC: 

• Have two or more layers of washable fabric 
• Completely cover your nose and mouth 
• Fit snugly against the sides of your face without gaps 
• Have a nose wire to prevent air from leaking out of the top of the mask 

Learn more about when to wear a mask on the CDC site.

According to the CDC, COVID-19 vaccines can be administered without regard to timing of other vaccines, including the flu vaccine. You can get the flu vaccine and the COVID-19 vaccine during the same visit. The CDC says that routine flu vaccination is an important part of preventive care for children, adolescents and adults (including pregnant people) that should not be delayed because of the COVID-19 pandemic.

Local public health agencies determine quarantine recommendations. According to the CDC, quarantine is used to keep someone who might have been exposed to COVID-19 away from others. Exposure is defined as 15 minutes or more of being within 6 feet of an individual who has tested positive or had symptoms within 2 days of exposure. By staying home or not going in public, quarantine helps prevent disease spread before a person knows they have the virus.

The CDC has identified 2 groups of people who do not need to quarantine when exposed:

• People who are fully vaccinated will no longer be required to quarantine following a direct exposure to someone with COVID-19, unless they are experiencing COVID-19 symptoms. Fully vaccinated people are considered those who have had both doses of a two-dose vaccine or the one-dose vaccine, and 2 weeks have passed to allow for the vaccine to work. There are additional considerations for patients and residents who are fully vaccinated and in health care settings.
• People who have recovered from COVID-19 in the past 3 months do not need to quarantine.

Learn more on the CDC website.

According to the CDC, isolation is used to separate people infected with COVID-19 from those who are not infected. People who are in isolation should stay home until it’s safe for them to be around others. At home, anyone sick or infected should separate from others, staying in a specific “sick room” and using a separate bathroom if possible. The length of the isolation period depends on several factors. Review the CDC’s recommendations for when isolation can end based on the situation.

According to the CDC, while most people get over COVID-19 within weeks of illness, some people experience post-COVID-19 conditions that continue 4 weeks or more after infection. Several recent studies show that between 27-33% of patients who get COVID-19 and were not hospitalized developed some lasting symptoms, no matter their age, prior health or severity of their infection. While much is still unknown, the CDC reports these “long-haul” conditions can come to life in a variety of ways, ranging from difficulty breathing, fatigue, joint pain or mood changes to even more serious issues like multi-organ damage or autoimmune conditions. FDA-authorized and FDA-approved COVID-19 vaccines play an important role in preventing serious illness from COVID-19. Additional information on "long haul"COVID-19 is available on the CDC website.

Here’s what we understand today: 

• Be prepared to show your photo ID, such as a driver’s license, to show proof of identity.
• Medicare plan members: 
  • You will need your red, white and blue Medicare card because Medicare is paying for your vaccine in 2021. If you don’t have your Medicare card, you can find it by logging in to your Social Security account. More information can be found on the CMS site.
  • If you receive your vaccine at a regular provider visit, you will also need your UnitedHealthcare member ID card.   
• Non-Medicare plan members: Bring your UnitedHealthcare member ID card. 

Remember to wear your face mask and to physically distance at your appointment. 

Additional information on preparing for your vaccination appointment can be found on the CDC website.

For many members, UnitedHealthcare pays an administrative fee to the vaccination provider that covers the member’s standard observation. By showing your health insurance card, you are also helping make sure there is a digital record of your COVID-19 vaccination available through your online UnitedHealthcare member account, which will help you keep a record of your vaccination status. 

If you receive additional services during your vaccination appointment or get the vaccination during a regular office visit, you may be responsible for copays, deductibles, coinsurance or out-of-network charges, according to your benefits plan.  Your vaccination provider should not charge you for the standard observation, which is the 15-30 minutes after receiving the vaccination.

Here are 3 key points from the CDC to keep in mind for your appointment: 

1. Allow extra time. Your vaccination provider will likely monitor you after receiving the vaccine. This is in case of a rare allergic reaction. So, you’ll want to plan some extra time.
2. Schedule the second dose. Plan ahead for your second dose by scheduling your second vaccine appointment if possible. You can also sign up for free text messaging through the CDC’s VaxText to a get a reminder about your second dose of the COVID-19 vaccine.
3. Keep vaccine cards in a safe place. You should receive a vaccination card during your appointment that says which vaccine you received, the date it was received and where it was received. We suggest you keep your vaccination card in a safe place.

If you are receiving an additional dose, your vaccination card will be updated to reflect those doses at your next appointment. We encourage you to keep your card with you.

If you are receiving the two-dose vaccine, you will need to get both doses within 3-4 weeks to get the protection indicated by the manufacturer. Make sure both doses you receive are from the same manufacturer and get your second dose as close to the recommended timing as possible. Follow the vaccination instructions from the manufacturer:

• Pfizer's Comirnaty COVID-19 vaccine: Requires 2 doses, given 3 weeks apart
• Moderna COVID-19 vaccine: Requires 2 doses, given 1 month apart
• Johnson & Johnson's Janssen COVID-19 vaccine: Requires no second dose

We strongly encourage members to schedule both doses at the same time to meet these time frames and get protection from COVID-19. The vaccination provider should assist the member with scheduling the second dose when they receive their first dose and help them know when to get the second dose.

You can also sign up for free text messaging through the CDC’s VaxText to a get a reminder about your second dose of the COVID-19 vaccine.

An additional dose of Johnson & Johnson’s Janssen vaccine is not yet authorized. There is no recommendation to start another vaccine series. The CDC and FDA are actively working to provide guidance on this.

The CDC recommends getting the next shot in your series as close to the recommended timing as possible. Follow the vaccination instructions from the manufacturer. If a member misses their vaccination appointment or are outside of the timing, they can still get the second dose and they won’t need to start over with a first dose. And even if the second dose is late, the second dose will still help them get protection from COVID-19. They should schedule their next appointment with their vaccination provider as soon as they can.

You should have received a vaccination card at your first appointment with information on the COVID-19 vaccine manufacturer, date of your first vaccination and when your second dose is due. If you cannot find that, your vaccination provider can help you know which vaccine you received.

The CDC says COVID-19 vaccine booster shots are available for the following Pfizer-BioNTech vaccine recipients who completed their initial series at least 6 months ago:

• 65 years and older
• 18+ who have underlying medical conditions
• 18+ who work in high-risk settings
• 18+ who live in high-risk settings

The CDC recommends and FDA have authorized an extra dose of COVID-19 vaccines for certain immunocompromised people as defined by CDC.

It is recommended for those eligible for the third dose of the Pfizer or Modera vaccines that people get it a minimum of 28 days after their second dose of the two-dose vaccine, ideally getting the same manufacturer as the first 2 shots. People who are immunocompromised, and those who live with them, should continue to wear face masks, physically distance and wash hands regularly when outside of their household. 

An additional dose of Johnson & Johnson’s Janssen vaccine is not yet authorized. The CDC and FDA are actively working to provide guidance on this.

To help ensure your safety, the CDC is recommending that you share your proof of vaccination card with your health care provider so they can confirm you meet the appropriate eligibility criteria.